Immigrant, Refugee, and Migrant Health Branch, Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30303, USA.
Travelers' Health Branch, Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30303, USA.
J Immigr Minor Health. 2021 Dec;23(6):1354-1358. doi: 10.1007/s10903-021-01270-z. Epub 2021 Sep 17.
We assessed the overseas gonorrhea results reported in the CDC's Electronic Disease Notification (EDN) system among refugees ≥ 15 years old who arrived in the United States during 2018. Of 18,720 refugees, 57 (0.4%) tested positive. Among those with a positive test, 31 (54.5%) were born in the Democratic Republic of the Congo, followed by 12 (21.1%) from Afghanistan. Thirty-three (57.9%) cases were female. Fifty-one cases (89.4%) were between 15 and 44 years of age; 25 (43.9%) were ages 15-24 and 26 (45.6%) were ages 25-44. Among the cases, 56 (98.2%) were treated overseas with the recommended therapy of ceftriaxone and azithromycin. Our findings suggest that the risk of gonorrhea in refugees is similar to that in the U.S. Given recent worldwide increases in gonorrhea, additional monitoring among refugees are necessary to assess the appropriateness of the gonorrhea screening requirement in the overseas medical examination.
我们评估了 2018 年抵达美国的年龄≥15 岁的难民在疾病预防控制中心电子疾病通报（EDN）系统中报告的海外淋病结果。在 18720 名难民中，有 57 人（0.4%）检测呈阳性。在检测呈阳性的人群中，有 31 人（54.5%）出生于刚果民主共和国，其次是 12 人（21.1%）来自阿富汗。33 例（57.9%）为女性。51 例（89.4%）年龄在 15 至 44 岁之间；25 例（43.9%）年龄在 15-24 岁之间，26 例（45.6%）年龄在 25-44 岁之间。在这些病例中，56 例（98.2%）在海外接受了头孢曲松和阿奇霉素推荐的治疗。我们的发现表明，难民中淋病的风险与美国相似。鉴于最近全球淋病的增加，有必要对难民进行额外监测，以评估海外体检中淋病筛查要求的适当性。
